The developments at Holland Capital in 2024 reflect our strong ambitions
Amsterdam/ Düsseldorf, 30th of December 2024 –The developments at Holland Capital in 2024 reflect our strong ambitions. Guided by a focused investment strategy, we continued to actively engage in the high-growth markets of Technology, Healthcare, and Agrifood. Reflecting on a successful year, we completed several key transactions and further strengthened our team.
2024 achievements
- The launch of our fund, Holland Capital Growth and Buy-Out Fund V
- Number of deals in the Netherlands: 5
- Number of add-on acquisitions in the Netherlands: 13
- Number of add-on acquisitions in Germany: 2
- Number of exits: 2
- Number of new colleagues: 4
Sector focus and an entrepreneurial hands-on approach: With specialized sector teams, we focus on the sectors of Healthcare, Technology, and Agrifood, both within the Growth & Buy-out and Venture & Growth segments. We understand the dynamics and opportunities in these sectors and have an extensive network. Holland Capital is not a passive investor; we work closely with management to define and execute strategies. Where needed, our operational team also contributes hands-on to the realization of specific projects within the company.
Which companies would we like to connect with?
- Sector: Technology, Healthcare, and Agrifood
- Positive outlook: Significant growth potential, both autonomous and buy-and-build
- Growth & Buy-out:
- Healthy profitability: cash flow from operations (EBITDA) between EUR 1 – 10m
- Smaller companies: considered as add-on acquisitions for our existing portfolio companies
- Larger companies: considered together with a co-investor
- Venture & Growth:
- Start-ups and scale-ups: EBITDA EUR <1m
- Cash flow negative (in an accelerated growth scenario)
- Revenue EUR 0 – 5m
What to expect from us?
- Flexible approach to transaction structures: We strive to adapt each structure to the needs of the company and its shareholders. Depending on the type of investment, Holland Capital either provides growth capital and/or acquires existing shares. We are flexible regarding the final capital structure: both majority and minority stakes are possible.
- Deal certainty and an efficient process: Thanks to our sector expertise, we are able to quickly assess a business model and put a fair price on the table. Since the partnership with the entrepreneur and/or the management team is the cornerstone of our investment, we devote above-average attention to ensuring the process is completed efficiently, in the right spirit, and with mutual respect for both parties.
- Transparency towards advisors: We appreciate it when advisors involve us early in discussions with entrepreneurs and/or management teams. In such cases, we always ensure that the advisor’s interests are well safeguarded throughout the process. The advisor retains the flexibility to decide whether to represent the sell-side or buy-side in a potential transaction.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare, Technology, and Agrifood-Tech sector.
Inno4Life receives funding for serialization in pharmacy and international growth
BOM, TIIN Capital, Holland Venture and the Zeeuws Investment Fund (ZIF) invest in life science machine building company.Breda, September 4, 2017 - Inno4Life, machine building company in the life science industries, will receive an investment from the Brabant...
Inno4Life ontvangt financiering voor serialisatie in farmacie en internationale groei
BOM, TIIN Capital, Holland Venture en het Zeeuws InvesteringsFonds investeren in life science-machinebouwbedrijf.Breda, 4 september 2017 - Inno4Life, machinebouwer in de life sciences-sector, ontvangt groeifinanciering van de Brabantse Ontwikkeling Maatschappij (BOM),...
Cloud services platform Eshgro ontvangt kapitaalinjectie van Holland Venture
Amsterdam, 4 juli 2017 – Investeringsmaatschappij Holland Venture investeert in Eshgro, een toonaangevend en innovatief cloud services platform. Het groeikapitaal stelt Eshgro in staat om haar unieke platform verder te ontwikkelen en haar internationale groei te...
Cloud services platform Eshgro receives capital injection from Holland Venture
Amsterdam, 4th of July 2017 – Growth capital investor Holland Venture invests in Eshgro, a leading and innovative cloud services platform. The growth capital investment enables Eshgro to further develop its unique platform and accelerate its international growth.Cloud...
QSight IT en Hoffmann bundelen krachten in strijd tegen cyberaanvallen
Met ingang van 15 mei 2017 werken QSight IT en Hoffmann Cybersecurity samen en bieden zo een integrale propositie op het gebied van cybersecurity. Daarmee vergroten zij de organisatorische, menselijke en technische cyberweerbaarheid van gezamenlijke opdrachtgevers....
Walter Balestra deelt zijn ervaringen over de snelgroeiende organisatie ZorgDomein
Amsterdam, 21 maart 2017 – Als CEO van de snelgroeiende organisatie ZorgDomein Nederland, deelde Walter Balestra tijdens de derde Holland Venture Growth Session zijn ervaringen over hoe zijn organisatie een centrale plek in het Nederlandse zorglandschap heeft...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl